Artivion, Inc.

AORT Healthcare Medical Devices

Artivion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $441.3 million, up 13.6% from fiscal 2024. In the quarter to June 2026, revenue grew 11.3%, EPS fell 1,033.3%, free cash flow fell 202.5% and total debt rose 67.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.

21.78 0.09 −0.41%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
142×
Dividend yield
—
F-score
7/9
Altman Z
3.73
Beneish M
−2.38
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(2.45%) 2.69% 3.14% (0.73%)
Piotroski F-Score
5 7 7 4
ROA
(1.10%) 1.17% 1.40% (0.33%)
ROIC
2.76% 3.51% 3.81% 1.76%
Return on Tangible Assets
(3.12%) 3.03% 3.51% (0.94%)
Average Days of Receivables
84.09 85.75 84.05 85.75
Free Cash Flow per Share
0.37 0.02 0.30 (0.19)
Free Cash Flow
17.50 0.84 14.58 (9.16)
Other line items

Show all line items

Columns are period end dates